One Sentence on the Label Can Turn Your Hair Product Into a Drug

The same bottle of shampoo can be a cosmetic or a drug under U.S. Law, depending entirely on what the label says it does. The Food and Drug Administration does not classify hair products by their ingredient list; it sorts them by their "intended use," a term that translates in practice to the claims printed on the package.

The Three Legal Boxes: Cosmetic, Drug, or Soap

The Federal Food, Drug, and Cosmetic Act sets up three possible categories for anything you pour, rub, or spray on your hair. A cosmetic is defined as an article intended for cleansing, beautifying, promoting attractiveness, or altering appearance, according to FDA guidance. A drug, by contrast, is an article intended for use in diagnosing, curing, mitigating, treating, or preventing disease, or for affecting the structure or function of the body. The soap category exists as a narrow carve-out: FDA applies it only when the bulk of the nonvolatile matter is an alkali salt of fatty acids and the product's detergent properties come solely from those compounds.

The legal distinction has real regulatory weight. Cosmetics enter the market without premarket FDA approval. Drugs face a far stricter gate.

Why "Soap" Is Harder to Claim Than It Sounds

Manufacturers sometimes assume that calling a product "soap" keeps it outside FDA's cosmetic and drug frameworks. The assumption is mostly wrong. FDA's interpretation requires that a product be labeled, sold, and represented solely as soap to qualify for the exemption. The chemistry matters too: the alkali-fatty acid composition must be the functional core. A product marketed with moisturizing claims, fragrance descriptions, or skin-conditioning promises has already stepped outside the soap box. Most items sold in the hair aisle do not meet FDA's soap definition even when they look like bars.

When Cleansing Keeps You in Cosmetic Territory

Plain shampoo occupies the safest ground. FDA explicitly states that shampoo is a cosmetic because its intended use is to cleanse the hair. The claim matches the statutory definition: beautifying and altering appearance. As long as the label stays in that lane, truthful and not misleading, the product avoids drug regulation. The manufacturer can launch without FDA pre-approval, though the product remains subject to adulteration and misbranding prohibitions.

The Claim That Triggers Drug Status

Add a disease-treatment promise and the classification flips. FDA uses antidandruff products as the textbook example: an antidandruff treatment is a drug because its intended use is to treat dandruff. An antidandruff shampoo is both a cosmetic and a drug because it cleanses hair and treats a scalp condition. The agency's guidance states that if a product is marketed with claims for treating or preventing disease, or for affecting the structure or function of the body, it is a drug under the law, even when it also affects appearance.

For hair products specifically, this means the boundary runs through wording like "restores growth," "blocks DHT," or "heals the scalp." The FDA has not published a list of hair-specific trigger phrases, but the underlying legal test is consistent: any claim that the product will treat a disease or change how the body functions—not merely how it looks—moves the item into drug territory.

Reading the Label for Legal Classification

A consumer or retailer can apply FDA's test directly to the package copy. Look first at the intended-use statement, often in smaller print near the ingredients. Language about cleansing, conditioning, shine, volume, or manageability keeps the product cosmetic. Language about treating, preventing, restoring, blocking, or healing pushes it toward drug status. The presence of a cosmetic effect does not save a product from drug classification if a disease-treatment or structure-function claim appears on the label.

One practical caveat: dual-status products exist. An antidandruff shampoo must satisfy both cosmetic and drug requirements. It needs the truthful labeling of a cosmetic and the approved active ingredient, adequate directions for use, and warning labels of an over-the-counter drug.

The Consequence of a Single Line

Hair product manufacturers sometimes draft labels iteratively, testing marketing language for consumer response. Each revision carries regulatory risk. A sentence added to emphasize clinical results, a before-and-after image suggesting disease treatment, or an ingredient call-out framed as therapeutic mechanism can reclassify the product without any change to the formula inside the bottle. The same chemistry then faces FDA's drug approval requirements, including the need for an approved new drug application or compliance with an applicable over-the-counter monograph. For a product already on shelves, a warning letter may follow. The label, not the laboratory, is where the law draws its line.